Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M al-Sarraf

Showing results (21-30 of 118) with videos related to

Pageof 12
Sort By:
American Journal of Clinical Oncology|August 1, 1988
Response rate and toxicity with aziridinylbenzoquinone in patients with recurrent gliomas. A progress reportE Tapazoglou, J Kish, J Ensley, et al.
American Journal of Clinical Oncology|February 1, 1990
Phase II evaluation of 4'deoxydoxorubicin in advanced renal cell carcinomaJ A Kish, J F Ensley, M al-Sarraf
Cancer Treatment Reports|June 1, 1979
Combination of adriamycin and cyclophosphamide in the treatment of metastatic prostatic carcinoma: a phase II studyR M Izbicki, M H Amer, M Al-Sarraf
Cancer|June 1, 1979
Factors that affect response to chemotherapy and survival of patients with advanced head and neck cancerM H Amer, M Al-Sarraf, V K Vaitkevicius
Cancer Treatment Reports|April 1, 1979
Phase II trial of dianhydrogalactitol in metastatic malignant melanoma: a Southwest Oncology Group studyJ T Thigpen, M Al-Sarraf, J S Hewlett
Cancer|March 15, 1986
The activity of a single-agent 5-fluorouracil infusion in advanced and recurrent head and neck cancerE Tapazoglou, J Kish, J Ensley, et al.
Cancer Treatment Reports|September 1, 1981
Phase II trial cisplatin, doxorubicin, and cyclophosphamide (CAP) in the treatment of urothelial transitional cell carcinomaM Campbell, L H Baker, M Opipari, et al.
Investigational New Drugs|December 1, 1988
Chemotherapy of the squamous cell lung cancer LC-12 with 5-fluorouracil, cisplatin, carboplatin or iproplatin combinationsE Tapazoglou, L Polin, T H Corbett, et al.
American Journal of Clinical Oncology|February 1, 1982
Phase II evaluation of 4'-(9-acridinylamino)-methanesulfon-m--anisidine (AMSA) in patients with advanced head and neck cancersV Ratanatharathorn, A Drelichman, M Sexon-Porte, et al.
American Journal of Clinical Oncology|April 1, 1986
Phase II clinical evaluation of AZQ in renal cell carcinomaD A Decker, J Kish, M Al-Sarraf, et al.
Pageof 12

Showing results (21-30 of 118) with videos related to

Sort By:
Pageof 12
American Journal of Clinical Oncology|August 1, 1988
Response rate and toxicity with aziridinylbenzoquinone in patients with recurrent gliomas. A progress reportE Tapazoglou, J Kish, J Ensley, et al.
American Journal of Clinical Oncology|February 1, 1990
Phase II evaluation of 4'deoxydoxorubicin in advanced renal cell carcinomaJ A Kish, J F Ensley, M al-Sarraf
Cancer Treatment Reports|June 1, 1979
Combination of adriamycin and cyclophosphamide in the treatment of metastatic prostatic carcinoma: a phase II studyR M Izbicki, M H Amer, M Al-Sarraf
Cancer|June 1, 1979
Factors that affect response to chemotherapy and survival of patients with advanced head and neck cancerM H Amer, M Al-Sarraf, V K Vaitkevicius
Cancer Treatment Reports|April 1, 1979
Phase II trial of dianhydrogalactitol in metastatic malignant melanoma: a Southwest Oncology Group studyJ T Thigpen, M Al-Sarraf, J S Hewlett
Cancer|March 15, 1986
The activity of a single-agent 5-fluorouracil infusion in advanced and recurrent head and neck cancerE Tapazoglou, J Kish, J Ensley, et al.
Cancer Treatment Reports|September 1, 1981
Phase II trial cisplatin, doxorubicin, and cyclophosphamide (CAP) in the treatment of urothelial transitional cell carcinomaM Campbell, L H Baker, M Opipari, et al.
Investigational New Drugs|December 1, 1988
Chemotherapy of the squamous cell lung cancer LC-12 with 5-fluorouracil, cisplatin, carboplatin or iproplatin combinationsE Tapazoglou, L Polin, T H Corbett, et al.
American Journal of Clinical Oncology|February 1, 1982
Phase II evaluation of 4'-(9-acridinylamino)-methanesulfon-m--anisidine (AMSA) in patients with advanced head and neck cancersV Ratanatharathorn, A Drelichman, M Sexon-Porte, et al.
American Journal of Clinical Oncology|April 1, 1986
Phase II clinical evaluation of AZQ in renal cell carcinomaD A Decker, J Kish, M Al-Sarraf, et al.
Pageof 12